News About: Pharm. Affairs
Leading presidential candidates, “Is it necessary to expand emergency household drugs?”
Leading presidential candidates have shown negative opinions over expanding the list of emergency household drugs.
The Minjoo Party, Liberty Korea Party, People’s Party, Bareun Party and Justice Party(number order) s...
Foreign pharmas more prefer Korean pharmacists than Korean pharmas do
It was surveyed overseas pharmaceutical companies are more interested in recruiting pharmacists than Korean ones.
At the symposium held for the ‘Future Job Openings and Professional Trainings in the Pharmaceutical In...
Current therapeutic categories for emergency household drug kept
While the discussion to adjust the list of emergency household drugs continues still, the chance for the list to be extended became higher.
The Ministry of Health and Welfare held the 2nd Council for Adjustment of th...
Chance to understand Japanese pharmaceutical market’s status, regulations and health insurance benefits
A chance will be arranged to understand information, health insurance benefits and regulatory information of the Japanese pharmaceutical market.
The ‘2nd Korea-Japan Private/Public Joint Medical Device Symposium’ wil...
Pharma industry agrees need of preferential treatments on biologics, but HIRA says “Well…”
Which health insurance standards should biologics, which are evaluated as innovative treatment, meet?
The pharmaceutical industry believes that it is necessary to give preference to Korean new drugs and biologics for...
KPA finally recovered the ‘lost 26 years’ back
The Korean Pharmaceutical Association(KPA) succeeded in searching for the root to recover 26 years lost.
The KPA passed an agenda to change the foundation day from 8 November 1954, a day the inaugural meeting of the ...
Pharma distribution field opposes to EZmedicom’s entry to drug bidding market
The pharmaceutical distribution field has made strong opposition to the EZmedicom’s entry to the drug bidding market.
According to the industry concerned on the 18th, Inje Education Foundation, a foundation of Paik H...
KPDS, “There is nothing to worry about side effects of Glivec generics”
Since concerns have been raised over the side effects of Glivec generics, a pharmacists’ association made an official opinion, “There is nothing to be concerned of.”
The Korean Pharmacists for Democratic Society(KPDS...
‘Basaglar,’ price-competitive biosimilar, launched in Korea
‘Basaglar,’ the first insulin glargine biosimilar in Korea, will be launched.
Lilly Korea and Boehringer Ingelheim Korea held a meeting to celebrate the launch of ‘Basaglar(generic name: insulin glargine 100U/ml),’ a...
Celltrion applies sales approval of Herzuma to enter Japanese market
Celltrion announced it applied sales approval of Herzuma(CT-P6, generic name: trastuzumab), a self-developed anticancer antibody biosimilar, at the Japanese Ministry of Health, Labour and Welfare on the 11th to enter ...
